Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)

The Lancet 2026

View at publisher
Authors: Brendon L. Neuen, Hiddo J. L. Heerspink, V Perkovic, D Cherney, C S P Lam, K R Tuttle, Christoph Wanner, Pantelis Sarafidis, S D Anker, G Filippatos, Bertram Pitt, P Rossing
+12 more Luis M Ruilope, Niels Jongs, J David Smeijer, Meike Brinker, Christiane Ahlers, Andrea Lage, Andrea Horvat-Bröcker, Patrick Schloemer, Thomas Eißing, Rania Dayoub, Robert Lawatscheck, Rajiv Agarwal
DOI: 10.1016/s0140-6736(26)01009-3
Cited by: 13
References: 24

Fields of Study & Subjects

Hormonal Regulation and Hypertension Adrenal Hormones and Disorders Estrogen and related hormone effects

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
407
Issue
10546
Pages
2375–2386
Publication date
1 June 2026
Language
EN